Stay updated with breaking news from Killert Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have identified fragments from influenza B viruses that the immune system consistently recognise, offering promising targets for a universal influenza B vaccine.
CON-CRĒT by Vireo Systems now holds the patent for research supporting creatine’s ability to help the body fight off coronavirus and influenza A.
CON-CRĒT by Vireo Systems now holds the patent for research supporting creatine’s ability to help the body fight off coronavirus and influenza A.
Killer T cells in older adults, directed against influenza viruses, closely resemble those found in newborns and children, but struggle to recognise infected cells.
T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.